approval · primary record
BRODALUMAB
FDA · BLA · 2026-05-07
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-05-07 |
| Brand | SILIQ |
| Sponsor | VALEANT LUXEMBOURG |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:33:57.591Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:BRODALUMAB:2026-05-07
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.